STC1 can enhance glucose metabolism, ATP production, and lactic acid production of lung cancer cells under normoxic and hypoxic conditions, thus achieving anti-apoptotic properties (Ohkouchi et al., 2012). This evidence concerns the gene STC1 and lung carcinoma.